420 with CNW — Analysis Finds Significant Number of US Employees Failing Cannabis Drug Tests

A study by testing company and medical lab Quest Diagnostics has revealed that Americans are failing marijuana tests in unprecedented numbers. The firm’s annual analysis found that the number of U.S. employees who tested positive for marijuana was the highest Quest Diagnostics had seen since it started collecting data on workplace drug testing in 1988.

After analyzing more than 6 million urine tests for traces of marijuana in 2022, the firm found that 4.3% were positive for cannabis compared to 3.9% in 2021. Quest Diagnostics tested urine samples from general employees. This group excludes safety-sensitive and federally mandated employees, such as truck drivers and pilots who go through regular drug testing.

Now that dozens of states have medical and recreational cannabis markets, millions of Americans have access to legal, regulated cannabis. However, since federal law still considers cannabis an illegal drug, cannabis users often find themselves facing legal repercussions for using cannabis in accordance with their state laws.

Quest’s data shows that despite the risks involved, American workers are consuming cannabis in greater numbers. The firm also revealed that 7.3% of general employees tested positive for cannabis following accidents on the job while 6.7% tested positive in 2021.

On the other hand, only 0.98% of employees in federally mandated safety-sensitive jobs tested positive for cannabis in 2022 up from 0.86% of employees in 2021.

Keith Ward, Quest Diagnostics general manager and vice president for employer solutions, suggested that the increase in cannabis use among employees may be due to evolving societal attitudes toward cannabis that are “impacting workplace behaviors.” In addition, Suhas Harwani, the company’s senior director of science for employee solutions, states that medical and recreational cannabis markets generally have higher rates of positive marijuana tests compared to the national average.

Unsurprisingly, states without legal marijuana markets had lower cannabis positivity rates. The report showed that 5.7% of general employees in states with legal recreational markets tested positive for cannabis in 2022 while the national average for marijuana positivity that year was 4.3%. Conversely, general employees in states with only medical cannabis markets had a positivity rate of 3.9%.

Several states across the country have adopted liberal policies toward cannabis over the past couple of decades, with more than 30 states now allowing their residents to use medical marijuana for specific conditions. In fact, the cannabis industry is now one of the fastest-growing sectors in the country, generating billions of dollars in revenue and hiring hundreds of thousands of employees.

Lawmakers are now working to pass cannabis banking regulations and legalize cannabis at the federal level.

Given that more than 30 states across the country permit the medical use of marijuana, it isn’t surprising that entities such as IGC Pharma Inc. (NYSE American: IGC) are taking this medical use a step further by developing formulations that can be approved by the FDA for use within the healthcare system.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Archives

Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722